ibandronate

Manufacturer:
Misc
Route of Administration: 
Oral, Intravenous
Site of Care:
Outpatient
Website: 
    Enrollment Forms:
    Synergen Prescription Form

    Approved Indication:

    treatment and prevention of osteoporosis in postmenopausal women

    Conditions:

    • Osteoporosis